Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Long intergenic non-protein coding RNA 919 (LINC00919)** is a member of the long intergenic non-coding RNAs (lincRNAs), a subclass of long non-coding RNAs (lncRNAs) that are transcribed from genomic regions distant from protein-coding genes and do not encode proteins[1][5][7]. lincRNAs, including LINC00919, typically exceed 200 nucleotides in length and are involved in diverse mechanisms of gene regulation at the epigenetic, transcriptional, and post-transcriptional level[7]. Although many lincRNAs have been functionally linked to processes such as cell differentiation, proliferation, and disease pathogenesis (especially cancers), **specific functional or disease associations for LINC00919 itself remain poorly characterized in the current available literature**[1][5]. No drugs are known to directly target LINC00919, and it is not classified as a receptor, enzyme, transporter, or typical drug target. **Notes and interpretation:** - LINC00919 is a non-coding RNA, not a canonical therapeutic target such as a receptor, enzyme, or transporter. - Its direct roles in cellular function or disease are not well-documented, with most sources only providing categorization as a lincRNA[1][5]. - There are no proofed data on drugs, biomarkers, or safety concerns specifically for LINC00919 in available curated resources. - lincRNAs generally act as transcriptional and post-transcriptional regulators and may be involved in disease processes, but for **LINC00919**, such applications are still unreported in referenced databases and literature as of this response[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 919 (LINC00919).